The hallmark BCR-ABL fusion in chronic myeloid leukemia (CML) and high expression of LMO2 in DLBCL both lead to BRCAness or HR deficient (HRD) phenotype [6, 15]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.